From October 1, 2022 to December 31, 2022, the company has repurchased 43,670 shares, representing 0.13% for KRW 454.87 million. With this, the company has completed the repurchase of 294,186 shares, representing 0.87% for KRW 2,998.6 million under the buyback announced on September 20, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,390 KRW | -0.31% | -1.99% | -27.22% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.22% | 156M | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.85% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on September 20, 2022.